 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Women Of Wonder |
| Street 1: | 838Msobomvu location madakana street Butterworth Eastern Cape South |
| Street 2: | Kwezi Ibika township |
| City: | Butterworth |
| Province: | |
| Post Code: | 4960 |
| Country: | South Africa |
| Phone: | 0644232438 |
| Organization Email: | trishjeantinzi@gmail.com |
| Web Site: | |
| Other Online Presence: | facebook and tiktok |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 228-233 |
| Organization Type - Primary: | Governmental Organization |
| Organization Type - Secondary: | None |
| Organization Description: | |
| Mission Statement The mission of Women of Wonder is to empower young women and girls living with HIV, TB, and other health conditions, promoting their economic independence, health, and well-being. Main Focus The main focus of Women of Wonder is to provide holistic support services to young women and girls living with HIV, TB, and other health conditions, addressing their economic, health, and social needs. Interest in Tuberculosis Women of Wonder is interested in tuberculosis (TB) because: 1. *High TB-HIV co-infection rate*: TB is the leading cause of death among people living with HIV, and South Africa has one of the highest TB-HIV co-infection rates in the world. 2. *Vulnerable populations*: Young women and girls living with HIV are disproportionately affected by TB, due to their compromised immune systems and socio-economic vulnerabilities. 3. *Stigma and discrimination*: TB is often stigmatized, leading to delayed diagnosis, treatment, and social isolation, which exacerbates the vulnerability of young women and girls living with HIV. TB Control Efforts Women of Wonder plans to: 1. *Provide TB awareness and education*: Conduct community outreach and sensitization campaigns to raise awareness about TB, its symptoms, and treatment options. 2. *Support TB testing and treatment*: Partner with local healthcare providers to offer TB testing and treatment services, ensuring that young women and girls living with HIV have access to timely and effective care. 3. *Promote TB prevention*: Encourage young women and girls living with HIV to adopt TB prevention measures, such as wearing masks, practicing good hygiene, and avoiding close contact with individuals with active TB. 4. *Advocate for TB policy change*: Collaborate with local stakeholders to advocate for policy changes that address the unique needs of young women and girls living with HIV and TB. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Advocacy Civil Society and Community Engagement Delivery of health services and care Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 6 - 10 |
| Number of full-time staff who are directly involved with TB: | 0 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 1 - 5 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | SANAC |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| "Our organization is committed to supporting the national health agenda, including the Nationality Control Plan. While we are not a health organization, our contributions come from our expertise in education, community development, or technology]. Some ways we're contributing include health education programs, community outreach. - Collaboration with other organizations, government agencies, or stakeholders to support the plan - Advocacy efforts to raise awareness about the importance of nationality control and the Nationality Control Plan We believe our contributions will help impact, e.g., improved health outcomes, increased access to health services, or enhanced community engagement. We look forward to continuing our support for the Nationality Control Plan and contributing to the overall well-being of our nation." |
|
Geographical Reach | |
| Which country is your headquarters located in: | South Africa |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
South Africa |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Women of Wonder is committed to contributing to the global plan to stop TB through TB care delivery, advocacy, communication, and social mobilization. Here are details of our efforts: TB Care Delivery 1. *TB Diagnosis and Treatment*: We partner with local healthcare providers to ensure that young women and girls living with TB have access to timely and accurate diagnosis, treatment, and care services. 2. *TB-HIV Co-infection Services*: We provide integrated TB-HIV services, including antiretroviral therapy (ART) and TB treatment, to address the high burden of TB-HIV co-infection among young women and girls. 3. *Community-Based TB Care*: We support community-based TB care initiatives, including community-based TB treatment and care, to reach vulnerable populations and improve treatment outcomes. Advocacy 1. *TB Policy Advocacy*: We advocate for policies that support TB care and prevention, including increased funding for TB programs, improved access to TB diagnosis and treatment, and reduced stigma and discrimination against people living with TB. 2. *Human Rights-Based Approach*: We promote a human rights-based approach to TB care, emphasizing the rights of people living with TB to access quality care, free from stigma and discrimination. 3. *Partnerships and Collaborations*: We collaborate with local and national stakeholders, including government agencies, civil society organizations, and community groups, to advocate for TB care and prevention. Communication 1. *TB Awareness and Education*: We conduct TB awareness and education campaigns, targeting young women and girls, to promote knowledge and understanding of TB prevention, diagnosis, and treatment. 2. *Stigma Reduction*: We implement stigma reduction initiatives, including community-based outreach and education programs, to reduce stigma and discrimination against people living with TB. 3. *Media Engagement*: We engage with local and national media outlets to promote TB awareness and education, and to advocate for TB care and prevention. Social Mobilization 1. *Community Engagement*: We engage with local communities, including community leaders, healthcare providers, and people living with TB, to promote TB awareness and education, and to support TB care and prevention efforts. 2. *Volunteer Program*: We establish a volunteer program, recruiting and training community volunteers to support TB care and prevention efforts, including community-based TB treatment and care. 3. *Partnerships with Community-Based Organizations*: We partner with community-based organizations, including civil society organizations and community groups, to support TB care and prevention efforts, and to promote TB awareness and education. Key Dates - 2020: Launched TB care delivery program in South Africa - 2022: Expanded TB care delivery program to Zambia and Zimbabwe - 2023: Launched advocacy and communication initiatives to promote TB awareness and education - 2025: Plan to scale up TB care delivery program to reach more young women and girls living with TB Countries of Involvement - South Africa - Zambia - Zimbabwe TB-HIV: Women of Women is committed to contributing to the global plan to stop TB, particularly in the area of TB and HIV. Here are details of our current and planned involvement: Current Involvement 1. *TB-HIV Awareness and Education*: We have been conducting community outreach and sensitization campaigns to raise awareness about TB-HIV co-infection, its symptoms, and treatment options in South Africa since 2020. 2. *Supporting TB-HIV Services*: We partner with local healthcare providers to offer TB-HIV testing and treatment services, ensuring that young women and girls living with HIV have access to timely and effective care in South Africa from 2020. Planned Involvement 1. *Scaling up TB-HIV Services*: We plan to expand our TB-HIV services to reach more young women and girls living with HIV in South Africa, Zambia, and Zimbabwe by 2025. 2. *Advocacy and Policy Change*: We plan to collaborate with local stakeholders to advocate for policy changes that address the unique needs of young women and girls living with HIV and TB in South Africa, Zambia, and Zimbabwe by 2025. 3. *Research and Data Collection*: We plan to conduct research and collect data on TB-HIV co-infection among young women and girls living with HIV in South Africa, Zambia, and Zimbabwe to inform policy and programming by 2025. Key Dates - 2020: Started conducting TB-HIV awareness and education campaigns in South Africa. - 2022: Expanded TB-HIV services to Zambia and Zimbabwe. - 2023: Started advocating for policy changes to address TB-HIV co-infection in South Africa, Zambia, and Zimbabwe. - 2025: Plan to complete research and data collection on TB-HIV co-infection among young women and girls living with HIV in South Africa, Zambia, and Zimbabwe. New Diagnostics: New Diagnostics 1. *Development of Rapid Diagnostic Tests*: We are working on developing rapid diagnostic tests for TB that can provide accurate results within minutes, enabling prompt treatment initiation. 2. *Evaluation of Point-of-Care Diagnostic Tools*: Our research involves evaluating the performance of point-of-care diagnostic tools, including their sensitivity, specificity, and usability. 3. *Molecular Diagnostic Assays*: We are developing molecular diagnostic assays for TB that can detect genetic material of the bacteria, enabling rapid and accurate diagnosis. New TB Drugs: Women of Wonder is committed to contributing to the global plan to stop TB, particularly in the area of newly TB drugs. Here are details of our current and planned involvement: Current Involvement1. *TB Drug Accessibility Advocacy*: We have been advocating for increased accessibility to newly TB drugs, such as bedaquiline and delamanid, for young women and girls living with TB in South Africa since 2022.2. *Partnership with TB Treatment Providers*: We partner with local healthcare providers to ensure that young women and girls living with TB have access to newly TB drugs and treatment services in South Africa from 2022. Planned Involvement1. *Scaling up TB Drug Accessibility*: We plan to expand our advocacy efforts to increase accessibility to newly TB drugs in Zambia and Zimbabwe by 2025.2. *Research and Data Collection*: We plan to conduct research and collect data on the effectiveness and accessibility of newly TB drugs for young women and girls living with TB in South Africa, Zambia, and Zimbabwe by 2025.3. *Capacity Building for Healthcare Providers*: We plan to provide training and capacity-building programs for healthcare providers on the use of newly TB drugs and treatment regimens in South Africa, Zambia, and Zimbabwe by 2025. Key Dates- 2022: Started advocating for increased accessibility to newly TB drugs in South Africa.- 2023: Expanded partnership with TB treatment providers to Zambia and Zimbabwe.- 2025: Plan to complete research and data collection on the effectiveness and accessibility of newly TB drugs. New TB Vaccines: New TB Vaccines 1. *Development of Novel TB Vaccine Candidates*: We are collaborating with partners to develop and test novel TB vaccine candidates, including those that target specific antigens or immune responses. 2. *Evaluation of TB Vaccine Efficacy*: Our research involves evaluating the efficacy and safety of new TB vaccines, including their ability to prevent infection, disease, and transmission. 3. *Investigating TB Vaccine-Induced Immunity*: We are exploring the immune responses induced by new TB vaccines, including the role of T cells, B cells, and cytokines in conferring protection. Key Partnerships 1. *Collaboration with Academic Institutions*: We partner with universities and research institutions to leverage expertise and resources in diagnostics and vaccine research. 2. *Partnership with Biotech Companies*: We collaborate with biotech companies to develop and test new diagnostic tools and vaccines. 3. *Engagement with Global Health Organizations*: We work with global health organizations, such as the World Health Organization (WHO) and the Stop TB Partnership, to inform policy and programming related to TB diagnostics and vaccines. Expected Outcomes 1. *Improved Diagnostic Accuracy*: Our work aims to improve the accuracy of TB diagnosis, reducing false positives and false negatives. 2. *Effective TB Vaccines*: We expect to contribute to the development of effective TB vaccines that can prevent infection, disease, and transmission. 3. *Enhanced TB Control and Elimination Efforts*: Our work aims to inform policy and programming related to TB control, ultimately contributing to the elimination of TB as a public health threat. |
|
Declaration | |
| Declaration of interests: As Women of Wonder, we declare the following interests that could constitute a real or potential or apparent conflict of interest with respect to the Global Partnership to Stop TB: Non-Financial Interests 1. _Capacity Building Support_: We receive capacity building support from Beyond Zero, which may influence our work and decisions related to TB control. No Financial Interests We do not receive any funding or financial support from any organization, including pharmaceutical companies, biotech firms, or other entities involved in TB research, diagnosis, and treatment. We declare this interest to ensure transparency and accountability in our work related to the Global Partnership to Stop TB. We commit to maintaining the integrity and independence of our organization. | |
| Application date: | February 11, 2025 |
| Last updated: | February 11, 2025 |